Your request to link to rcsb for Prostaglandin E synthase/G/H synthase 2

• 1CVU: crystal structure of arachidonic acid bound to the cyclooxygenase active site of cox-2 (10.1038/35011103 )
• 1CX2: cyclooxygenase-2 (prostaglandin synthase-2) complexed with a selective inhibitor, sc-558 (10.1038/384644A0 )
• 1DDX: crystal structure of a mixture of arachidonic acid and prostaglandin bound to the cyclooxygenase active site of cox-2: prostaglandin structure (10.1038/35011103 )
• 1PXX: crystal structure of diclofenac bound to the cyclooxygenase active site of cox-2 (10.1074/JBC.M305481200 )
• 3HS5: x-ray crystal structure of arachidonic acid bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M110.119867 )
• 3HS6: x-ray crystal structure of eicosapentaenoic acid bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M110.119867 )
• 3HS7: x-ray crystal structure of docosahexaenoic acid bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M110.119867 )
• 3KRK: x-ray crystal structure of arachidonic acid bound in the cyclooxygenase channel of l531f murine cox-2 (10.1074/JBC.M110.119867 )
• 3LN0: structure of compound 5c-s bound at the active site of cox-2 (10.1016/J.BMCL.2010.07.054 )
• 3LN1: structure of celecoxib bound at the cox-2 active site (10.1016/J.BMCL.2010.07.054 )
• 3MDL: x-ray crystal structure of 1-arachidonoyl glycerol bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M111.230367 )
• 3MQE: structure of sc-75416 bound at the cox-2 active site (10.1016/J.BMCL.2010.07.054 )
• 3NT1: high resolution structure of naproxen:cox-2 complex. (10.1074/JBC.M110.162982 )
• 3NTB: structure of 6-methylthio naproxen analog bound to mcox-2. (10.1074/JBC.M110.162982 )
• 3NTG: crystal structure of cox-2 with selective compound 23d-(r) (10.1016/J.BMCL.2010.07.054 )
• 3OLT: x-ray crystal structure of arachidonic acid bound to the cyclooxygenase channel of r513h murine cox-2 (10.1074/JBC.M111.230367 )
• 3OLU: x-ray crystal structure of 1-arachidonoyl glycerol bound to the cyclooxygenase channel of r513h murine cox-2 (10.1074/JBC.M111.230367 )
• 3PGH: cyclooxygenase-2 (prostaglandin synthase-2) complexed with a non- selective inhibitor, flurbiprofen (10.1038/384644A0 )
• 3Q7D: structure of (r)-naproxen bound to mcox-2. (10.1038/NCHEMBIO.663 )
• 3QH0: x-ray crystal structure of palmitic acid bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M111.231969 )
• 3QMO: x-ray crystal structure of ns-398 bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1016/J.JSB.2011.07.019 )
• 3RR3: structure of (r)-flurbiprofen bound to mcox-2 (10.1038/NCHEMBIO.663 )
• 3TZI: x-ray crystal structure of arachidonic acid bound in the cyclooxygenase channel of g533v murine cox-2 (10.1074/JBC.M112.372243 )
• 4COX: cyclooxygenase-2 (prostaglandin synthase-2) complexed with a non- selective inhibitor, indomethacin (10.1038/384644A0 )
• 4E1G: x-ray crystal structure of alpha-linolenic acid bound to the cyclooxygenase channel of cyclooxygenase-2 (10.1074/JBC.M112.372243 )
• 4FM5: x-ray structure of des-methylflurbiprofen bound to murine cox-2 (10.1021/ML3001616 )
• 4M10: crystal structure of murine cyclooxygenase-2 complex with isoxicam (10.1074/JBC.M113.517987 )
• 4M11: crystal structure of murine cyclooxygenase-2 complex with meloxicam (10.1074/JBC.M113.517987 )
• 4OTJ: the complex of murine cyclooxygenase-2 with a conjugate of indomefathin and podophyllotoxin, n-{(succinylpodophyllotoxinyl)but- 4-yl}-2-{1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3- yl}acetamide (10.1021/ACSCHEMBIO.6B00560 )
• 4OTY: crystal structure of lumiracoxib bound to the apo-mouse- cyclooxygenase-2 (10.1016/J.BMCL.2013.08.097 )
• 4PH9: the structure of ibuprofen bound to cyclooxygenase-2 (10.1016/J.JSB.2014.11.005 )
• 4RRW: crystal structure of apo murine cyclooxygenase-2 (10.1074/JBC.M114.635987 )
• 4RRX: crystal structure of apo murine v89w cyclooxygenase-2 complexed with lumiracoxib (10.1074/JBC.M114.635987 )
• 4RRY: crystal structure of apo murine h90w cyclooxygenase-2 (10.1074/JBC.M114.635987 )
• 4RRZ: crystal structure of apo murine h90w cyclooxygenase-2 complexed with lumiracoxib (10.1074/JBC.M114.635987 )
• 4RS0: crystal structure of murine h90w cyclooxygenase-2 complexed with s- ibuprofen (10.1074/JBC.M114.635987 )
• 4RUT: crystal structure of murine cyclooxygenase-2 with 13-methyl- arachidonic acid (10.1074/JBC.M114.634014 )
• 4Z0L: the murine cyclooxygenase-2 complexed with a nido-dicarbaborate- containing indomethacin derivative (10.1002/CMDC.201500199 )
• 5COX: uninhibited mouse cyclooxygenase-2 (prostaglandin synthase-2) (10.1038/384644A0 )
• 5F19: the crystal structure of aspirin acetylated human cyclooxygenase-2 (10.1021/ACS.BIOCHEM.5B01378 )
• 5F1A: the crystal structure of salicylate bound to human cyclooxygenase-2 (10.1021/ACS.BIOCHEM.5B01378 )
• 5FDQ: murine cox-2 s530t mutant (10.1021/ACS.BIOCHEM.5B01378 )
• 5IKQ: the structure of meclofenamic acid bound to human cyclooxygenase-2 (10.1074/JBC.M116.725713 )
• 5IKR: the structure of mefenamic acid bound to human cyclooxygenase-2 (10.1074/JBC.M116.725713 )
• 5IKT: the structure of tolfenamic acid bound to human cyclooxygenase-2 (10.1074/JBC.M116.725713 )
• 5IKV: the structure of flufenamic acid bound to human cyclooxygenase-2 (10.1074/JBC.M116.725713 )
• 5JVY: crystal structure of s121p murine cox-2 mutant (10.1074/JBC.M116.757310 )
• 5JVZ: crystal structure of flurbiprofen bound to s121p murine cox-2 mutant (10.1074/JBC.M116.757310 )
• 5JW1: crystal structure of celecoxib bound to s121p murine cox-2 mutant (10.1074/JBC.M116.757310 )
• 5KIR: the structure of vioxx bound to human cox-2 (10.1107/S2053230X16014230 )
• 5W58: crystal complex of cyclooxygenase-2: (s)-arn-2508 (a dual cox and faah inhibitor) (10.1074/JBC.M117.802058 )
• 6BL3: crystal complex of cyclooxygenase-2 with indomethacin-butyldiamine- dansyl conjugate (10.1074/JBC.RA119.007405 )
• 6BL4: crystal complex of cyclooxygenase-2 with indomethacin-ethylenediamine- dansyl conjugate (10.1074/JBC.RA119.007405 )
• 6COX: cyclooxygenase-2 (prostaglandin synthase-2) complexed with a selective inhibitor, sc-558 in i222 space group (10.1038/384644A0 )
• 6OFY: crystal structure of arachidonic acid bound to v349i murine cox-2 (10.1021/ACS.BIOCHEM.9B00659 )
• 6V3R: crystal structure of murine cycloxygenase in complex with a harmaline analog, 4,9-dihydro-3h-pyrido[3,4-b]indole (10.1021/ACSMEDCHEMLETT.9B00555 )